In parallel with our observation in vitro, tumor size and weight in the erastin group were significantly increased by TMEM147 overexpression, whereas GW297X pretreatment markedly reversed this TMEM147-mediated oncogenic effect (Fig. 5e). This evidence concerns the gene TMEM147 and neoplasm.